MYHE:NASDAQState Street My2031 High Yield Corporate Bond ETF Analysis
Data as of 2026-05-29 - not real-time
$25.05
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
MYHE is trading at $25.05, essentially hugging its calculated resistance level of $25.045. The 20‑day, 50‑day and 200‑day SMAs are tightly clustered around $24.90, indicating a flat price base. Momentum indicators are supportive: the RSI sits at 58, and the MACD histogram is positive with a bullish signal line crossover. The fund’s beta of 0.33 and 30‑day volatility of roughly 4.5% underscore a defensive, low‑volatility profile. With an expense ratio of 0.39%, the cost structure is in line with peers in the high‑yield space. The underlying high‑yield corporate bond basket benefits from the current Extreme Greed sentiment (FGI 94), which typically fuels demand for yield. However, the fund’s net asset value of $24.998 is marginally below the market price, suggesting a slight premium but no material tracking error.
Liquidity is a notable concern—average daily volume hovers around 1,000 shares for a fund with only $5 M in assets, placing liquidity risk at a high level. The support level of $24.65 provides a modest cushion, while the max drawdown of just over 2% reflects limited downside so far. Given the bullish technical setup but constrained trading activity, a short‑term “hold” stance is prudent. Over the medium horizon, the 2031 target maturity aligns with expectations for a flattening yield curve, supporting a “buy” recommendation. Long‑term investors can rely on the fund’s fixed maturity and the continued attractiveness of high‑yield credit in a low‑rate environment. Overall, the blend of defensive risk metrics and attractive yield potential makes MYHE a modestly appealing addition for patient, yield‑seeking portfolios. Investors should monitor liquidity and credit spread developments, as these will be the primary drivers of performance.
Liquidity is a notable concern—average daily volume hovers around 1,000 shares for a fund with only $5 M in assets, placing liquidity risk at a high level. The support level of $24.65 provides a modest cushion, while the max drawdown of just over 2% reflects limited downside so far. Given the bullish technical setup but constrained trading activity, a short‑term “hold” stance is prudent. Over the medium horizon, the 2031 target maturity aligns with expectations for a flattening yield curve, supporting a “buy” recommendation. Long‑term investors can rely on the fund’s fixed maturity and the continued attractiveness of high‑yield credit in a low‑rate environment. Overall, the blend of defensive risk metrics and attractive yield potential makes MYHE a modestly appealing addition for patient, yield‑seeking portfolios. Investors should monitor liquidity and credit spread developments, as these will be the primary drivers of performance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price testing resistance at $25.05
- stable but low volume suggests liquidity constraints
- bullish MACD and RSI above 50 support short‑term upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- target maturity 2031 aligns with yield‑curve expectations
- low beta (0.33) provides defensive profile
- expense ratio 0.39% is competitive for high‑yield exposure
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- high‑yield corporate bond exposure benefits from elevated credit spreads
- extreme greed market sentiment may sustain demand
- fixed 2031 horizon offers predictable cash‑flow profile
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.39%
AUM$5.0M
Inception Date2026-02-25
Avg Daily Volume1,020
Premium/Discount0.00%
Tracking Error0.00%
Technical Analysis
TrendBullish
RSI58.1
Support$24.65
Resistance$25.05
MA 20$24.90
MA 50$24.88
MA 200$24.88
MACDBullish
VolumeStable
Fear & Greed Index94.07
Risk Assessment
Beta0.33
Volatility4.50%
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.